Suardi Nazareno, Capitanio Umberto, Chun Felix K H, Graefen Markus, Perrotte Paul, Schlomm Thorsten, Haese Alexander, Huland Hartwig, Erbersdobler Andreas, Montorsi Francesco, Karakiewicz Pierre I
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada.
Cancer. 2008 Oct 15;113(8):2068-72. doi: 10.1002/cncr.23827.
Active surveillance (AS) represents a treatment option for select patients with low-risk, organ-confined prostate cancer (PCa). In this report, the authors addressed the rates of misclassification associated with the use of 5 different clinical criteria for AS. Misclassification was defined as the presence of either nonorgan-confined disease or high-grade PCa.
Between 1992 and 2007, 4885 patients underwent radical prostatectomy (RP) at 1 of 2 European academic centers, and the patients were identified who fulfilled the criteria for AS according to 5 different investigational groups (Hardie et al, Roemeling et al, Choo et al, Klotz, and D'Amico and Coleman). Statistics targeted the rates of misclassification for each of the 5 definitions.
Four thousand three hundred eight patients, 4047 patients, 3993 patients, 2455 patients, and 2345 patients fulfilled the AS criteria of Hardie et al, Roemeling et al, Choo et al, Klotz, and D'Amico and Coleman, respectively. Extracapsular extension was reported in 13.5% to 26% of patients, and seminal vesicle invasion was reported in 2.9% to 8.2% of patients. When PCa with Gleason scores from 8 to 10 at RP was considered high grade, the misclassification rates were 27%, 25%, 25%, 15%, and 14% for the 5 studies, respectively. Conversely, when PCa with Gleason scores from 7 to 10 was considered high grade, the misclassification rates increased to 56%, 55%, 45%, 42%, and 39%, respectively.
The currently available AS criteria are limited by a high rate of misclassification. The use of more selective AS criteria may reduce the rate of misclassification but also may reduce significantly the percentage of patients who may be considered for AS.
主动监测(AS)是部分低风险、器官局限性前列腺癌(PCa)患者的一种治疗选择。在本报告中,作者探讨了使用5种不同临床标准进行AS时的误诊率。误诊定义为存在非器官局限性疾病或高级别PCa。
1992年至2007年期间,4885例患者在2个欧洲学术中心之一接受了根治性前列腺切除术(RP),并确定了根据5个不同研究组(哈迪等人、罗梅林等人、朱等人、克洛茨以及达米科和科尔曼)的标准符合AS条件的患者。统计针对5种定义各自的误诊率。
分别有4308例、4047例、3993例、2455例和2345例患者符合哈迪等人、罗梅林等人、朱等人、克洛茨以及达米科和科尔曼的AS标准。13.5%至26%的患者报告有包膜外侵犯,2.9%至8.2%的患者报告有精囊侵犯。当将RP时Gleason评分8至10的PCa视为高级别时,5项研究的误诊率分别为27%、25%、25%、15%和14%。相反,当将Gleason评分7至10的PCa视为高级别时,误诊率分别增至56%、55%、45%、42%和39%。
目前可用的AS标准受高误诊率限制。使用更具选择性的AS标准可能会降低误诊率,但也可能显著减少可考虑接受AS治疗的患者比例。